National and Kapodistrian University of Athens
Μοριακή μελέτη της παθογένειας των κρανιοσκελετικών ανωμαλιών: ανάλυση των εμπλεκόμενων γονιδίων και των σηματοδοτικών μονοπατιών
Abstract
dc:descriptionCranioskeletal dysplasias can be divided into two major groups: skeletal dysplasias andcraniosynostosis. Craniosynostosis, the premature fusion of cranial sutures is further divided intosyndromic and non syndromic. The common craniosynostosis syndromes Muenke,Crouzon/Crouzon with acanthosis nigricans, Apert, Pfeiffer, Saethre-Chotzen and CFNS arecaused by mutations in FGFR1-3, TWIST1 and EFNB1 genes.FGF receptors 1-3 as well as the transcription factors TWIST1 and RUNX2 play veryimportant roles in controlling osteoblast proliferation and differentiation. Probably, they interactduring osteoblastogenesis and suture formation, thus belonging to the same pathway, eventhough the way they interact is not clear, due to inconsistency of experimental results.Craniosynostosis induced by FGFR2 and maybe TWIST1 mutations is the result of prematureor improper osteoblast differentiation at bone fronts in which increased cell proliferation maybeinvolved as well, following several different mechanisms.The aims of this study are:Α) Detection of underlying genetic cause in patients with cranioskeletal dysplasias, whichwill contribute in more accurate genotype-phenotype correlation as well as in proper patientmanagement.Β) Understanding the signaling pathway leading to craniosynostosis. In order to succeedthis we chose to study relative expression levels of the transcription factors RUNX2 and TWIST1,known to play important roles in the regulation of osteoblast differentiation, as well as COL1A1,as a differentiation marker, in patients with syndromic or non syndromic craniosynostosis andnormal individuals, in skin fibroblast cell cultures under growth conditions.C) Development of skin fibroblast cultures as a potential model for the study of differentialexpression of genes related to premature suture fusion. This model’s utility is worth evaluatingfor two reasons: fibroblasts are developmentally related to osteoblasts, therefore representinga particularly relevant cell type and they can be easily cultured and manipulated.For this study biological samples (blood/skin) were collected from 48 patients with cranioskeletal anomalies and from 2 normal regarding synostosis individuals (positional plagiocephaly and normal control sample), who presented in the Hellenic Craniofacial center atMITERA Hospital.Molecular analysis of selected genetic loci using sequencing, AFLP and/or MLPA revealedmutations in 14/46 craniosynostosis patients (molecular diagnosis at ~30%). In total, 9 differentmutations were found in FGFR2, FGFR3, TWIST1 and EFNB1 genes, of which 3 were novel, aheterozygous TWIST1 gene deletion and a FGFR3 polymorphism. Two of the novel mutations, themissense E125K and the frameshift L240fsX79, are within EFNB1 gene. E125K mutation, whichlies within ephrin domain of EFNB1, is expected to disrupt the interaction between the Ephreceptor and ephrin B1 ligand. L240fsX79 mutation results in a truncated, probably unstableprotein product. The third novel mutation, missense L138P which lies within highly conservedHLH domain of TWIST1, possibly results in loss of DNA binding capacity of the transcription factor.Molecular genetic testing of craniosynostosis patients is of great importance because itallows accurate genotype-phenotype correlation and can lead to molecular diagnosis, thusallowing proper patient’s management, genetic counseling and prenatal diagnosis.Study of relative expression levels of RUNX2, TWIST1 and COL1A1 genes, known to beexpressed in osteoblasts and play important role in their proliferation and differentiation, wasperformed in skin fibroblasts from patients with syndromic craniosynostosis, carrying mutationseither in FGFR2 or TWIST1 genes, from patients with non syndromic synostosis, from one patientwith positional plagiocephaly and from a normal individual. Cells were cultured under growthconditions.The differences in gene expression levels observed in our patients, although relativelysmall, reveal a differentiated expression pattern between pathogenic and normal samples, aswell as among pathogenic samples compared to each other.Even though further studies of RUNX2, TWIST1 and COL1A1 gene expression are required in skin fibroblasts, experimental results of this study point out that all of these genes are involvedin craniosynostosis signaling pathway, but in different ways, depending on the context.As opposed to the efforts in creating a simple, unifying model, applied to allcraniosynostosis cases, it seems that signaling pathways triggered either by FGFR2 and TWIST1mutations or in isolated synostosis cases are very different compared to each other. These results are the first targeted study of RUNX2, TWIST1 and COL1A1 gene expressionin skin fibroblasts from patients with syndromic or non syndromic craniosynostosis and fromindividuals without synostosis.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Apostolopoulou, Despina
- Αποστολοπούλου, Δέσποινα
Subjects
dc:subject × 18- Κρανιοσυνοστέωση
- Κρανιοσκελετικές ανωμαλίες
- Γονίδια FGFR1, FGFR2, FGFR3
- Γονίδιo TWIST1
- Γονίδιo EFNB1
- Craniosgnostosis
- TWIST1 gene
- Cranioskeletal anomalies
- FGFR1, FGFR2, FGFR3 genes
- EFNB1 gene
- Φυσικές Επιστήμες
- Βιολογία
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Natural Sciences
- Biological Sciences
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43512